Brian M Calimlim (B M Calimlim, Brian Calimlim)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 18

Top Topics

Atopic Dermatitis

Top Venues

American journal of clinical dermatology

Journal of the European Academy of Dermatology and Venereology : JEADV

Dermatology and therapy

Dermatitis : contact, atopic, occupational, drug

This page only lists publications with an associated author ORCID identifier.

Publications

Jonathan Ian Silverberg, Melinda J Gooderham, Amy S Paller, Mette Deleuran, Christopher G Bunick, Linda F Stein Gold, Dirk-Jan Hijnen, Brian M Calimlim, Wan-Ju Lee, Henrique D Teixeira, Xiaofei Hu, Shiyu Zhang, Yang Yang, Ayman Grada, Andrew M Platt, Diamant Thaҫi
Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2). American journal of clinical dermatology (2024)
Jonathan Ian Silverberg, Melinda J Gooderham, Amy S Paller, Mette Deleuran, Christopher G Bunick, Linda F Stein Gold, Dirk-Jan Hijnen, Brian M Calimlim, Wan-Ju Lee, Henrique D Teixeira, Xiaofei Hu, Shiyu Zhang, Yang Yang, Ayman Grada, Andrew M Platt, Diamant Thaҫi
Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2). American journal of clinical dermatology 25 (3) (2024)
Jonathan Ian Silverberg, Melinda J Gooderham, Amy S Paller, Mette Deleuran, Christopher G Bunick, Linda F Stein Gold, Dirk-Jan Hijnen, Brian M Calimlim, Wan-Ju Lee, Henrique D Teixeira, Xiaofei Hu, Shiyu Zhang, Yang Yang, Ayman Grada, Andrew M Platt, Diamant Thaҫi
Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2). American journal of clinical dermatology 25 (3) (2024)
Jonathan Ian Silverberg, Melinda J Gooderham, Amy S Paller, Mette Deleuran, Christopher G Bunick, Linda F Stein Gold, Dirk-Jan Hijnen, Brian M Calimlim, Wan-Ju Lee, Henrique D Teixeira, Xiaofei Hu, Shiyu Zhang, Yang Yang, Ayman Grada, Andrew M Platt, Diamant Thaҫi
Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2). American journal of clinical dermatology 25 (3) (2024)
Eric L Simpson, Vimal H Prajapati, Yael A Leshem, Raj Chovatiya, Marjolein de Bruin-Weller, Pamela Guglielmini, Andrew E Pink, Brian M Calimlim, Wan-Ju Lee, Henrique Teixeira, Barry Ladizinski, Xiaofei Hu, Yang Yang, Yingyi Liu, Meng Liu, Ayman Grada, Andrew M Platt, Jonathan Ian Silverberg
Upadacitinib Rapidly Improves Patient-Reported Outcomes in Atopic Dermatitis: 16-Week Results from Phase 3 Clinical Trials (Measure Up 1 and 2). Dermatology and therapy 14 (5) (2024)
Jonathan Ian Silverberg, Melinda J Gooderham, Amy S Paller, Mette Deleuran, Christopher G Bunick, Linda F Stein Gold, Dirk-Jan Hijnen, Brian M Calimlim, Wan-Ju Lee, Henrique D Teixeira, Xiaofei Hu, Shiyu Zhang, Yang Yang, Ayman Grada, Andrew M Platt, Diamant Thaҫi
Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2). American journal of clinical dermatology 25 (3) (2024)
Eric L Simpson, Vimal H Prajapati, Yael A Leshem, Raj Chovatiya, Marjolein de Bruin-Weller, Pamela Guglielmini, Andrew E Pink, Brian M Calimlim, Wan-Ju Lee, Henrique Teixeira, Barry Ladizinski, Xiaofei Hu, Yang Yang, Yingyi Liu, Meng Liu, Ayman Grada, Andrew M Platt, Jonathan Ian Silverberg
Upadacitinib Rapidly Improves Patient-Reported Outcomes in Atopic Dermatitis: 16-Week Results from Phase 3 Clinical Trials (Measure Up 1 and 2). Dermatology and therapy 14 (5) (2024)
Eric L Simpson, Vimal H Prajapati, Yael A Leshem, Raj Chovatiya, Marjolein de Bruin-Weller, Pamela Guglielmini, Andrew E Pink, Brian M Calimlim, Wan-Ju Lee, Henrique Teixeira, Barry Ladizinski, Xiaofei Hu, Yang Yang, Yingyi Liu, Meng Liu, Ayman Grada, Andrew M Platt, Jonathan Ian Silverberg
Upadacitinib Rapidly Improves Patient-Reported Outcomes in Atopic Dermatitis: 16-Week Results from Phase 3 Clinical Trials (Measure Up 1 and 2). Dermatology and therapy (2024)
Eric L Simpson, Vimal H Prajapati, Yael A Leshem, Raj Chovatiya, Marjolein de Bruin-Weller, Pamela Guglielmini, Andrew E Pink, Brian M Calimlim, Wan-Ju Lee, Henrique Teixeira, Barry Ladizinski, Xiaofei Hu, Yang Yang, Yingyi Liu, Meng Liu, Ayman Grada, Andrew M Platt, Jonathan Ian Silverberg
Upadacitinib Rapidly Improves Patient-Reported Outcomes in Atopic Dermatitis: 16-Week Results from Phase 3 Clinical Trials (Measure Up 1 and 2). Dermatology and therapy 14 (5) (2024)
Kristian Reich, M S de Bruin-Weller, M Deleuran, Brian M Calimlim, N Chen, X Hu, A R Tenorio, Jonathan Ian Silverberg
Higher Levels of Response on Clinical Atopic Dermatitis Severity Measures Are Associated with Meaningful Improvements in Patient-Reported Symptom and Quality of Life Measures: Integrated Analysis of Three Upadacitinib Phase 3 Trials. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Kristian Reich, M S de Bruin-Weller, M Deleuran, Brian M Calimlim, N Chen, X Hu, A R Tenorio, Jonathan Ian Silverberg
Higher levels of response on clinical atopic dermatitis severity measures are associated with meaningful improvements in patient-reported symptom and quality of life measures: Integrated analysis of three Upadacitinib phase 3 trials. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Jacob Pontoppidan Thyssen, D Thaçi, T Bieber, Melinda J Gooderham, M de Bruin-Weller, W Soong, K Kabashima, Sébastien Barbarot, P C Luna, J Xu, X Hu, Y Liu, E M Raymundo, Brian M Calimlim, C Nduaka, A Gamelli, Eric L Simpson
Upadacitinib for moderate-to-severe atopic dermatitis: stratified analysis from three randomized phase 3 trials by key baseline characteristics. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Emma Guttman-Yassky, Jonathan Ian Silverberg, Diamant Thaçi, Kim A Papp, Sonja Ständer, Lisa A Beck, Brian S Kim, Xiaofei Hu, Jianzhong Liu, Brian M Calimlim, Namita Vigna, Jameson T Crowley, Henrique D Teixeira, Jacob Pontoppidan Thyssen
Upadacitinib treatment withdrawal and retreatment in patients with moderate-to-severe atopic dermatitis: results from a phase 2b, randomized, controlled trial. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Kilian Eyerich, Melinda J Gooderham, Juan Francisco Silvestre, Stephen P Shumack, Pedro Mendes Bastos, Valeria Aoki, Michela Ortoncelli, Jonathan Ian Silverberg, Henrique D Teixeira, Shirley H Chen, Brian M Calimlim, Shunya Takemoto, Cristina Sancho, Björn Fritz, Alan D Irvine
Real-World Clinical, Psychosocial, and Economic Burden of Atopic Dermatitis: Results From a Multicountry Study. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Jonathan Ian Silverberg, Marjolein de Bruin-Weller, Brian M Calimlim, Xiaofei Hu, Sarah A Ofori, Andrew M Platt, Henrique D Teixeira, Kilian Eyerich, Jacob Pontoppidan Thyssen
Aggregate Response Benefit in Skin Clearance and Itch Reduction With Upadacitinib or Dupilumab in Patients With Moderate-to-Severe Atopic Dermatitis. Dermatitis : contact, atopic, occupational, drug (2023)
Shawn G Kwatra, Peter A Lio, Stephan Weidinger, Brian M Calimlim, Barry Ladizinski, Namita Vigna, Willings Botha, Carol A Mansfield
Patient preferences for atopic dermatitis treatments: a discrete choice experiment. The Journal of dermatological treatment 34 (1) (2023)
Jonathan Ian Silverberg, Marjolein de Bruin-Weller, Brian M Calimlim, Xiaofei Hu, Sarah A Ofori, Andrew M Platt, Henrique D Teixeira, Kilian Eyerich, Jacob Pontoppidan Thyssen
Aggregate Response Benefit in Skin Clearance and Itch Reduction With Upadacitinib or Dupilumab in Patients With Moderate-to-Severe Atopic Dermatitis®. Dermatitis : contact, atopic, occupational, drug 35 (3) (2023)
Hiroyuki Murota, Yuta Koike, Kanako Ishii, Brian M Calimlim, Maja Ludwikowska, Mondher Toumi, Isao Kawaguchi
Evaluating the burden of pruritus due to atopic dermatitis in Japan by patient-reported outcomes. Journal of medical economics 24 (1) (2021)